| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.809 | 0.004 | 0.839 | Cholinergic | 0.815 0.003 DBMET03138 0.839 0.003 DBMET03139 0.539 0.005 DBMET03140 0.8 0.004 DBMET03146 0.631 0.005 DBMET03147 0.807 0.004 DBMET03148 0.638 0.004 DBMET03141 0.656 0.004 DBMET03142 0.774 0.004 DBMET03149 0.809 0.004 DBMET03150 0.815 0.003 DBMET03151 0.631 0.005 DBMET03153 0.815 0.003 DBMET03156 0.638 0.004 DBMET03157 | DBMET03139 | |
| 0.799 | 0.003 | 0.833 | Acetylcholinesterase inhibitor | 0.803 0.003 DBMET03138 0.833 0.003 DBMET03139 0.526 0.005 DBMET03140 0.781 0.003 DBMET03146 0.607 0.004 DBMET03147 0.792 0.003 DBMET03148 0.617 0.004 DBMET03141 0.636 0.004 DBMET03142 0.752 0.003 DBMET03149 0.799 0.003 DBMET03150 0.803 0.003 DBMET03151 0.607 0.004 DBMET03153 0.803 0.003 DBMET03156 0.617 0.004 DBMET03157 | DBMET03139 | |
| 0.765 | 0.008 | 0.851 | Analgesic | 0.845 0.005 DBMET03138 0.817 0.005 DBMET03139 0.534 0.04 DBMET03140 0.736 0.01 DBMET03146 0.574 0.032 DBMET03147 0.799 0.006 DBMET03148 0.596 0.028 DBMET03141 0.563 0.034 DBMET03142 0.851 0.005 DBMET03149 0.765 0.008 DBMET03150 0.845 0.005 DBMET03151 0.574 0.032 DBMET03153 0.845 0.005 DBMET03156 0.596 0.028 DBMET03157 | DBMET03149 | |
| 0.695 | 0.006 | 0.705 | Nootropic | 0.705 0.006 DBMET03138 0.643 0.008 DBMET03139 0.325 0.063 DBMET03140 0.678 0.007 DBMET03146 0.516 0.018 DBMET03147 0.635 0.009 DBMET03148 0.474 0.024 DBMET03141 0.586 0.011 DBMET03142 0.595 0.011 DBMET03149 0.695 0.006 DBMET03150 0.705 0.006 DBMET03151 0.516 0.018 DBMET03153 0.705 0.006 DBMET03156 0.474 0.024 DBMET03157 | DBMET03156 | |
| 0.635 | 0.003 | 0.747 | Opioid antagonist | 0.739 0.003 DBMET03138 0.553 0.004 DBMET03139 0.392 0.005 DBMET03140 0.618 0.004 DBMET03146 0.463 0.004 DBMET03147 0.666 0.003 DBMET03148 0.439 0.004 DBMET03141 0.542 0.004 DBMET03142 0.747 0.003 DBMET03149 0.635 0.003 DBMET03150 0.739 0.003 DBMET03151 0.463 0.004 DBMET03153 0.739 0.003 DBMET03156 0.439 0.004 DBMET03157 | DBMET03149 | |
| 0.635 | 0.003 | 0.73 | Analgesic, opioid | 0.73 0.003 DBMET03138 0.612 0.003 DBMET03139 0.408 0.005 DBMET03140 0.617 0.003 DBMET03146 0.545 0.004 DBMET03147 0.617 0.003 DBMET03148 0.455 0.004 DBMET03141 0.535 0.004 DBMET03142 0.7 0.003 DBMET03149 0.635 0.003 DBMET03150 0.73 0.003 DBMET03151 0.545 0.004 DBMET03153 0.73 0.003 DBMET03156 0.455 0.004 DBMET03157 | DBMET03156 | |
| 0.557 | 0.003 | 0.676 | Opioid mu receptor antagonist | 0.669 0.003 DBMET03138 0.48 0.004 DBMET03139 0.317 0.005 DBMET03140 0.535 0.004 DBMET03146 0.39 0.004 DBMET03147 0.581 0.003 DBMET03148 0.323 0.005 DBMET03141 0.479 0.004 DBMET03142 0.676 0.003 DBMET03149 0.557 0.003 DBMET03150 0.669 0.003 DBMET03151 0.39 0.004 DBMET03153 0.669 0.003 DBMET03156 0.323 0.005 DBMET03157 | DBMET03149 | |
| 0.552 | 0.004 | 0.57 | Butyrylcholinesterase inhibitor | 0.556 0.004 DBMET03138 0.57 0.004 DBMET03139 0.233 0.017 DBMET03140 0.535 0.004 DBMET03146 0.346 0.008 DBMET03147 0.544 0.004 DBMET03148 0.276 0.012 DBMET03141 0.332 0.009 DBMET03142 0.497 0.005 DBMET03149 0.552 0.004 DBMET03150 0.556 0.004 DBMET03151 0.346 0.008 DBMET03153 0.556 0.004 DBMET03156 0.276 0.012 DBMET03157 | DBMET03139 | |
| 0.541 | 0.004 | 0.667 | Opioid agonist | 0.663 0.003 DBMET03138 0.485 0.004 DBMET03139 0.254 0.005 DBMET03140 0.529 0.004 DBMET03146 0.373 0.004 DBMET03147 0.569 0.003 DBMET03148 0.271 0.005 DBMET03141 0.326 0.004 DBMET03142 0.667 0.003 DBMET03149 0.541 0.004 DBMET03150 0.663 0.003 DBMET03151 0.373 0.004 DBMET03153 0.663 0.003 DBMET03156 0.271 0.005 DBMET03157 | DBMET03149 | |
| 0.535 | 0.003 | 0.64 | Opioid kappa receptor antagonist | 0.634 0.002 DBMET03138 0.442 0.004 DBMET03139 0.413 0.004 DBMET03140 0.518 0.003 DBMET03146 0.422 0.004 DBMET03147 0.562 0.003 DBMET03148 0.416 0.004 DBMET03141 0.406 0.004 DBMET03142 0.64 0.002 DBMET03149 0.535 0.003 DBMET03150 0.634 0.002 DBMET03151 0.422 0.004 DBMET03153 0.634 0.002 DBMET03156 0.416 0.004 DBMET03157 | DBMET03149 | |
| 0.527 | 0.004 | 0.683 | Opioid delta receptor antagonist | 0.677 0.003 DBMET03138 0.307 0.005 DBMET03139 0.268 0.005 DBMET03140 0.501 0.004 DBMET03146 0.264 0.005 DBMET03147 0.56 0.004 DBMET03148 0.273 0.005 DBMET03141 0.253 0.005 DBMET03142 0.683 0.003 DBMET03149 0.527 0.004 DBMET03150 0.677 0.003 DBMET03151 0.264 0.005 DBMET03153 0.677 0.003 DBMET03156 0.273 0.005 DBMET03157 | DBMET03149 | |
| 0.514 | 0.003 | 0.635 | Opioid mu receptor agonist | 0.631 0.003 DBMET03138 0.403 0.004 DBMET03139 0.255 0.004 DBMET03140 0.465 0.003 DBMET03146 0.339 0.004 DBMET03147 0.553 0.003 DBMET03148 0.265 0.004 DBMET03141 0.287 0.004 DBMET03142 0.635 0.003 DBMET03149 0.514 0.003 DBMET03150 0.631 0.003 DBMET03151 0.339 0.004 DBMET03153 0.631 0.003 DBMET03156 0.265 0.004 DBMET03157 | DBMET03149 | |
| 0.478 | 0.048 | 0.519 | Transcription factor NF kappa B inhibitor | 0.476 0.048 DBMET03138 0.26 0.12 DBMET03139 0.286 0.103 DBMET03140 0.519 0.041 DBMET03146 0.304 0.092 DBMET03147 0.379 0.068 DBMET03148 0.368 0.071 DBMET03141 0.288 0.101 DBMET03142 0.43 0.057 DBMET03149 0.478 0.048 DBMET03150 0.476 0.048 DBMET03151 0.304 0.092 DBMET03153 0.476 0.048 DBMET03156 0.368 0.071 DBMET03157 | DBMET03146 | |
| 0.456 | 0.045 | 0.485 | Immunosuppressant | 0.485 0.037 DBMET03138 0.272 0.133 DBMET03139 0.39 0.068 DBMET03140 0.455 0.046 DBMET03146 0.375 0.074 DBMET03147 0.244 0.152 DBMET03148 0.443 0.049 DBMET03141 0.409 0.059 DBMET03142 0.314 0.106 DBMET03149 0.456 0.045 DBMET03150 0.485 0.037 DBMET03151 0.375 0.074 DBMET03153 0.485 0.037 DBMET03156 0.443 0.049 DBMET03157 | DBMET03156 | |
| 0.42 | 0.014 | 0.42 | P-glycoprotein inhibitor | 0.344 0.022 DBMET03138 0.21 0.058 DBMET03139 0.231 0.048 DBMET03140 0.331 0.024 DBMET03146 0.202 0.062 DBMET03147 0.34 0.022 DBMET03148 0.194 0.068 DBMET03141 0.171 0.089 DBMET03142 0.257 0.039 DBMET03149 0.42 0.014 DBMET03150 0.344 0.022 DBMET03151 0.202 0.062 DBMET03153 0.344 0.022 DBMET03156 0.194 0.068 DBMET03157 | ||
| 0.481 | 0.08 | 0.481 | Apoptosis agonist | 0.467 0.085 DBMET03138 0.364 0.131 DBMET03140 0.441 0.095 DBMET03146 0.295 0.176 DBMET03147 0.472 0.083 DBMET03148 0.316 0.161 DBMET03141 0.263 0.201 DBMET03142 0.469 0.084 DBMET03149 0.481 0.08 DBMET03150 0.467 0.085 DBMET03151 0.295 0.176 DBMET03153 0.467 0.085 DBMET03156 0.316 0.161 DBMET03157 | ||
| 0.415 | 0.021 | 0.415 | Antimitotic | 0.352 0.032 DBMET03138 0.383 0.026 DBMET03139 0.385 0.025 DBMET03146 0.205 0.081 DBMET03147 0.192 0.089 DBMET03142 0.415 0.021 DBMET03150 0.352 0.032 DBMET03151 0.205 0.081 DBMET03153 0.352 0.032 DBMET03156 | ||
| 0.407 | 0.021 | 0.409 | Psychostimulant | 0.409 0.021 DBMET03138 0.163 0.105 DBMET03139 0.203 0.078 DBMET03140 0.369 0.028 DBMET03146 0.373 0.027 DBMET03148 0.253 0.057 DBMET03141 0.376 0.027 DBMET03149 0.407 0.021 DBMET03150 0.409 0.021 DBMET03151 0.409 0.021 DBMET03156 0.253 0.057 DBMET03157 | DBMET03156 | |
| 0.39 | 0.026 | 0.454 | Amyloid beta aggregation inhibitor | 0.398 0.025 DBMET03138 0.172 0.094 DBMET03139 0.145 0.112 DBMET03140 0.347 0.035 DBMET03146 0.208 0.073 DBMET03147 0.426 0.021 DBMET03148 0.187 0.085 DBMET03142 0.454 0.019 DBMET03149 0.39 0.026 DBMET03150 0.398 0.025 DBMET03151 0.208 0.073 DBMET03153 0.398 0.025 DBMET03156 | DBMET03149 | |
| 0.413 | 0.069 | 0.474 | 15-Lipoxygenase inhibitor | 0.448 0.055 DBMET03138 0.214 0.198 DBMET03140 0.324 0.115 DBMET03146 0.328 0.113 DBMET03147 0.391 0.078 DBMET03148 0.347 0.101 DBMET03142 0.474 0.046 DBMET03149 0.413 0.069 DBMET03150 0.448 0.055 DBMET03151 0.328 0.113 DBMET03153 0.448 0.055 DBMET03156 | DBMET03149 | |
| 0.342 | 0.012 | 0.342 | Protein kinase stimulant | 0.341 0.013 DBMET03138 0.145 0.072 DBMET03139 0.263 0.023 DBMET03140 0.277 0.02 DBMET03146 0.287 0.019 DBMET03148 0.284 0.019 DBMET03141 0.116 0.097 DBMET03142 0.329 0.014 DBMET03149 0.342 0.012 DBMET03150 0.341 0.013 DBMET03151 0.341 0.013 DBMET03156 0.284 0.019 DBMET03157 | ||
| 0.314 | 0.003 | 0.375 | Opioid kappa receptor agonist | 0.373 0.002 DBMET03138 0.312 0.003 DBMET03139 0.254 0.004 DBMET03140 0.304 0.003 DBMET03146 0.278 0.003 DBMET03147 0.326 0.003 DBMET03148 0.253 0.004 DBMET03141 0.258 0.004 DBMET03142 0.375 0.002 DBMET03149 0.314 0.003 DBMET03150 0.373 0.002 DBMET03151 0.278 0.003 DBMET03153 0.373 0.002 DBMET03156 0.253 0.004 DBMET03157 | DBMET03149 | |
| 0.337 | 0.026 | 0.388 | Anesthetic general | 0.361 0.022 DBMET03138 0.163 0.101 DBMET03140 0.214 0.067 DBMET03146 0.321 0.029 DBMET03148 0.388 0.018 DBMET03149 0.337 0.026 DBMET03150 0.361 0.022 DBMET03151 0.361 0.022 DBMET03156 | DBMET03149 | |
| 0.33 | 0.025 | 0.426 | Platelet adhesion inhibitor | 0.328 0.025 DBMET03138 0.158 0.097 DBMET03139 0.23 0.057 DBMET03140 0.358 0.018 DBMET03146 0.413 0.01 DBMET03147 0.325 0.026 DBMET03148 0.221 0.061 DBMET03141 0.426 0.009 DBMET03142 0.323 0.027 DBMET03149 0.33 0.025 DBMET03150 0.328 0.025 DBMET03151 0.413 0.01 DBMET03153 0.328 0.025 DBMET03156 0.221 0.061 DBMET03157 | DBMET03142 | |
| 0.288 | 0.004 | 0.527 | Opioid delta receptor agonist | 0.499 0.003 DBMET03138 0.11 0.005 DBMET03139 0.088 0.006 DBMET03140 0.292 0.004 DBMET03146 0.087 0.006 DBMET03147 0.342 0.004 DBMET03148 0.094 0.005 DBMET03141 0.072 0.008 DBMET03142 0.527 0.003 DBMET03149 0.288 0.004 DBMET03150 0.499 0.003 DBMET03151 0.087 0.006 DBMET03153 0.499 0.003 DBMET03156 0.094 0.005 DBMET03157 | DBMET03149 | |
| 0.33 | 0.052 | 0.427 | Hypoxia-inducible factor 1 alpha inhibitor | 0.325 0.054 DBMET03138 0.201 0.15 DBMET03140 0.277 0.078 DBMET03146 0.396 0.031 DBMET03148 0.427 0.024 DBMET03149 0.33 0.052 DBMET03150 0.325 0.054 DBMET03151 0.325 0.054 DBMET03156 | DBMET03149 | |
| 0.33 | 0.066 | 0.425 | Caspase 3 stimulant | 0.295 0.081 DBMET03138 0.208 0.158 DBMET03139 0.208 0.158 DBMET03140 0.289 0.084 DBMET03146 0.425 0.037 DBMET03148 0.409 0.042 DBMET03149 0.33 0.066 DBMET03150 0.295 0.081 DBMET03151 0.295 0.081 DBMET03156 | DBMET03148 | |
| 0.338 | 0.079 | 0.362 | Vasodilator, peripheral | 0.238 0.137 DBMET03138 0.362 0.069 DBMET03146 0.209 0.166 DBMET03148 0.338 0.079 DBMET03150 0.238 0.137 DBMET03151 0.238 0.137 DBMET03156 | DBMET03146 | |
| 0.314 | 0.057 | 0.432 | Antioxidant | 0.372 0.041 DBMET03138 0.231 0.094 DBMET03139 0.239 0.09 DBMET03140 0.323 0.054 DBMET03146 0.32 0.055 DBMET03147 0.332 0.051 DBMET03148 0.312 0.057 DBMET03141 0.379 0.039 DBMET03142 0.432 0.03 DBMET03149 0.314 0.057 DBMET03150 0.372 0.041 DBMET03151 0.32 0.055 DBMET03153 0.372 0.041 DBMET03156 0.312 0.057 DBMET03157 | DBMET03149 | |
| 0.297 | 0.046 | 0.379 | 5 Hydroxytryptamine uptake stimulant | 0.271 0.063 DBMET03138 0.206 0.139 DBMET03139 0.379 0.018 DBMET03146 0.339 0.029 DBMET03148 0.19 0.172 DBMET03141 0.31 0.04 DBMET03149 0.297 0.046 DBMET03150 0.271 0.063 DBMET03151 0.271 0.063 DBMET03156 0.19 0.172 DBMET03157 | DBMET03146 | |
| 0.318 | 0.074 | 0.328 | Vasodilator, coronary | 0.245 0.14 DBMET03138 0.328 0.067 DBMET03146 0.214 0.169 DBMET03148 0.318 0.074 DBMET03150 0.245 0.14 DBMET03151 0.245 0.14 DBMET03156 | DBMET03146 | |
| 0.274 | 0.036 | 0.293 | Peptidyltransferase inhibitor | 0.293 0.027 DBMET03138 0.255 0.047 DBMET03139 0.164 0.16 DBMET03140 0.276 0.035 DBMET03146 0.266 0.04 DBMET03141 0.232 0.065 DBMET03142 0.274 0.036 DBMET03150 0.293 0.027 DBMET03151 0.293 0.027 DBMET03156 0.266 0.04 DBMET03157 | DBMET03156 | |
| 0.288 | 0.075 | 0.381 | Spasmolytic | 0.309 0.067 DBMET03138 0.297 0.071 DBMET03139 0.165 0.15 DBMET03140 0.232 0.099 DBMET03147 0.339 0.056 DBMET03148 0.185 0.133 DBMET03142 0.381 0.044 DBMET03149 0.288 0.075 DBMET03150 0.309 0.067 DBMET03151 0.232 0.099 DBMET03153 0.309 0.067 DBMET03156 | DBMET03149 | |
| 0.213 | 0.005 | 0.232 | Toll-Like receptor 4 antagonist | 0.232 0.004 DBMET03138 0.199 0.006 DBMET03139 0.169 0.013 DBMET03140 0.218 0.005 DBMET03146 0.158 0.017 DBMET03147 0.199 0.006 DBMET03148 0.173 0.012 DBMET03141 0.165 0.014 DBMET03142 0.215 0.005 DBMET03149 0.213 0.005 DBMET03150 0.232 0.004 DBMET03151 0.158 0.017 DBMET03153 0.232 0.004 DBMET03156 0.173 0.012 DBMET03157 | DBMET03156 | |
| 0.239 | 0.046 | 0.272 | Hepatoprotectant | 0.231 0.05 DBMET03138 0.204 0.062 DBMET03139 0.223 0.053 DBMET03140 0.225 0.052 DBMET03146 0.272 0.038 DBMET03147 0.24 0.046 DBMET03148 0.191 0.071 DBMET03141 0.243 0.045 DBMET03142 0.242 0.045 DBMET03149 0.239 0.046 DBMET03150 0.231 0.05 DBMET03151 0.272 0.038 DBMET03153 0.231 0.05 DBMET03156 0.191 0.071 DBMET03157 | DBMET03153 | |
| 0.243 | 0.053 | 0.264 | Nitric oxide antagonist | 0.242 0.054 DBMET03138 0.208 0.065 DBMET03139 0.2 0.067 DBMET03140 0.24 0.054 DBMET03146 0.153 0.092 DBMET03147 0.251 0.051 DBMET03148 0.211 0.063 DBMET03141 0.162 0.086 DBMET03142 0.264 0.048 DBMET03149 0.243 0.053 DBMET03150 0.242 0.054 DBMET03151 0.153 0.092 DBMET03153 0.242 0.054 DBMET03156 0.211 0.063 DBMET03157 | DBMET03149 | |
| 0.342 | 0.152 | 0.365 | Caspase 9 stimulant | 0.3 0.193 DBMET03138 0.365 0.134 DBMET03146 0.355 0.141 DBMET03148 0.333 0.16 DBMET03149 0.342 0.152 DBMET03150 0.3 0.193 DBMET03151 0.3 0.193 DBMET03156 | DBMET03146 | |
| 0.254 | 0.073 | 0.4 | Tumour necrosis factor alpha release inhibitor | 0.4 0.027 DBMET03139 0.241 0.079 DBMET03146 0.219 0.093 DBMET03147 0.295 0.055 DBMET03148 0.254 0.073 DBMET03150 0.219 0.093 DBMET03153 | DBMET03139 | |
| 0.204 | 0.031 | 0.247 | Cholinergic antagonist | 0.247 0.021 DBMET03138 0.187 0.036 DBMET03139 0.16 0.047 DBMET03146 0.186 0.036 DBMET03148 0.219 0.027 DBMET03149 0.204 0.031 DBMET03150 0.247 0.021 DBMET03151 0.247 0.021 DBMET03156 | DBMET03156 | |
| 0.218 | 0.061 | 0.269 | Neurotrophic factor enhancer | 0.219 0.06 DBMET03138 0.204 0.073 DBMET03146 0.247 0.04 DBMET03148 0.269 0.029 DBMET03149 0.218 0.061 DBMET03150 0.219 0.06 DBMET03151 0.219 0.06 DBMET03156 | DBMET03149 | |
| 0.171 | 0.022 | 0.175 | Antineoplastic alkaloid | 0.175 0.021 DBMET03138 0.096 0.05 DBMET03139 0.106 0.044 DBMET03140 0.142 0.03 DBMET03146 0.112 0.041 DBMET03148 0.104 0.045 DBMET03141 0.139 0.031 DBMET03149 0.171 0.022 DBMET03150 0.175 0.021 DBMET03151 0.175 0.021 DBMET03156 0.104 0.045 DBMET03157 | DBMET03156 | |
| 0.139 | 0.01 | 0.142 | ATPase (Vacuolar H+) inhibitor | 0.137 0.011 DBMET03138 0.128 0.015 DBMET03139 0.103 0.036 DBMET03140 0.142 0.01 DBMET03146 0.083 0.07 DBMET03147 0.116 0.023 DBMET03141 0.109 0.029 DBMET03142 0.139 0.01 DBMET03150 0.137 0.011 DBMET03151 0.083 0.07 DBMET03153 0.137 0.011 DBMET03156 0.116 0.023 DBMET03157 | DBMET03146 | |
| 0.215 | 0.09 | 0.273 | Antiamyloidogenic | 0.194 0.104 DBMET03138 0.165 0.128 DBMET03146 0.269 0.063 DBMET03148 0.273 0.061 DBMET03149 0.215 0.09 DBMET03150 0.194 0.104 DBMET03151 0.194 0.104 DBMET03156 | DBMET03149 | |
| 0.146 | 0.037 | 0.146 | Expectorant | 0.106 0.062 DBMET03138 0.124 0.048 DBMET03140 0.117 0.053 DBMET03146 0.132 0.043 DBMET03148 0.089 0.083 DBMET03141 0.116 0.054 DBMET03149 0.146 0.037 DBMET03150 0.106 0.062 DBMET03151 0.106 0.062 DBMET03156 0.089 0.083 DBMET03157 | ||
| 0.216 | 0.109 | 0.324 | 5 Hydroxytryptamine release stimulant | 0.221 0.105 DBMET03138 0.324 0.063 DBMET03146 0.285 0.075 DBMET03148 0.285 0.075 DBMET03149 0.216 0.109 DBMET03150 0.221 0.105 DBMET03151 0.221 0.105 DBMET03156 | DBMET03146 | |
| 0.153 | 0.054 | 0.172 | Toll-Like receptor antagonist | 0.167 0.045 DBMET03138 0.142 0.062 DBMET03146 0.17 0.043 DBMET03148 0.172 0.042 DBMET03149 0.153 0.054 DBMET03150 0.167 0.045 DBMET03151 0.167 0.045 DBMET03156 | DBMET03149 | |
| 0.126 | 0.037 | 0.14 | Antineoplastic antibiotic | 0.14 0.033 DBMET03138 0.103 0.045 DBMET03139 0.099 0.047 DBMET03140 0.139 0.034 DBMET03146 0.08 0.057 DBMET03147 0.121 0.038 DBMET03141 0.121 0.038 DBMET03142 0.126 0.037 DBMET03150 0.14 0.033 DBMET03151 0.08 0.057 DBMET03153 0.14 0.033 DBMET03156 0.121 0.038 DBMET03157 | DBMET03156 | |
| 0.125 | 0.036 | 0.371 | Breast cancer-resistant protein inhibitor | 0.096 0.059 DBMET03138 0.106 0.05 DBMET03146 0.141 0.027 DBMET03147 0.208 0.013 DBMET03148 0.371 0.005 DBMET03142 0.157 0.021 DBMET03149 0.125 0.036 DBMET03150 0.096 0.059 DBMET03151 0.141 0.027 DBMET03153 0.096 0.059 DBMET03156 | DBMET03142 | |
| 0.142 | 0.055 | 0.172 | Acetylcholine antagonist | 0.172 0.039 DBMET03138 0.111 0.079 DBMET03146 0.135 0.059 DBMET03148 0.158 0.046 DBMET03149 0.142 0.055 DBMET03150 0.172 0.039 DBMET03151 0.172 0.039 DBMET03156 | DBMET03156 | |
| 0.122 | 0.036 | 0.156 | Alpha 2 adrenoreceptor antagonist | 0.11 0.041 DBMET03138 0.118 0.037 DBMET03146 0.156 0.025 DBMET03148 0.115 0.039 DBMET03149 0.122 0.036 DBMET03150 0.11 0.041 DBMET03151 0.11 0.041 DBMET03156 | DBMET03148 | |
| 0.133 | 0.048 | 0.151 | Microtubule formation inhibitor | 0.115 0.067 DBMET03138 0.151 0.037 DBMET03146 0.133 0.048 DBMET03150 0.115 0.067 DBMET03151 0.115 0.067 DBMET03156 | DBMET03146 | |
| 0.095 | 0.017 | 0.183 | Sigma receptor antagonist | 0.162 0.01 DBMET03138 0.065 0.025 DBMET03146 0.137 0.012 DBMET03148 0.183 0.009 DBMET03149 0.095 0.017 DBMET03150 0.162 0.01 DBMET03151 0.162 0.01 DBMET03156 | DBMET03149 | |
| 0.095 | 0.017 | 0.413 | NMDA 2B receptor antagonist | 0.12 0.012 DBMET03138 0.076 0.023 DBMET03146 0.413 0.004 DBMET03147 0.361 0.004 DBMET03142 0.058 0.033 DBMET03149 0.095 0.017 DBMET03150 0.12 0.012 DBMET03151 0.413 0.004 DBMET03153 0.12 0.012 DBMET03156 | DBMET03153 | |
| 0.122 | 0.044 | 0.139 | Electron transport complex I inhibitor | 0.108 0.066 DBMET03138 0.114 0.056 DBMET03146 0.139 0.028 DBMET03148 0.124 0.042 DBMET03149 0.122 0.044 DBMET03150 0.108 0.066 DBMET03151 0.108 0.066 DBMET03156 | DBMET03148 | |
| 0.152 | 0.079 | 0.199 | Melanin inhibitor | 0.167 0.062 DBMET03138 0.172 0.058 DBMET03146 0.157 0.073 DBMET03148 0.199 0.041 DBMET03149 0.152 0.079 DBMET03150 0.167 0.062 DBMET03151 0.167 0.062 DBMET03156 | DBMET03149 | |
| 0.121 | 0.054 | 0.168 | Estrogen antagonist | 0.13 0.038 DBMET03138 0.1 0.099 DBMET03139 0.115 0.066 DBMET03146 0.131 0.037 DBMET03148 0.168 0.018 DBMET03149 0.121 0.054 DBMET03150 0.13 0.038 DBMET03151 0.13 0.038 DBMET03156 | DBMET03149 | |
| 0.205 | 0.141 | 0.22 | Gastrin inhibitor | 0.22 0.119 DBMET03138 0.19 0.165 DBMET03148 0.199 0.151 DBMET03149 0.205 0.141 DBMET03150 0.22 0.119 DBMET03151 0.22 0.119 DBMET03156 | DBMET03156 | |
| 0.11 | 0.047 | 0.17 | Estrogen receptor beta antagonist | 0.119 0.033 DBMET03138 0.104 0.057 DBMET03146 0.127 0.025 DBMET03148 0.17 0.013 DBMET03149 0.11 0.047 DBMET03150 0.119 0.033 DBMET03151 0.119 0.033 DBMET03156 | DBMET03149 | |
| 0.177 | 0.117 | 0.314 | Free radical scavenger | 0.237 0.074 DBMET03138 0.2 0.098 DBMET03146 0.194 0.103 DBMET03148 0.199 0.099 DBMET03141 0.314 0.048 DBMET03149 0.177 0.117 DBMET03150 0.237 0.074 DBMET03151 0.237 0.074 DBMET03156 0.199 0.099 DBMET03157 | DBMET03149 | |
| 0.095 | 0.039 | 0.123 | Alpha 2a adrenoreceptor antagonist | 0.123 0.028 DBMET03138 0.101 0.036 DBMET03146 0.107 0.033 DBMET03148 0.118 0.03 DBMET03149 0.095 0.039 DBMET03150 0.123 0.028 DBMET03151 0.123 0.028 DBMET03156 | DBMET03156 | |
| 0.14 | 0.085 | 0.237 | Acetylcholine M1 receptor antagonist | 0.206 0.04 DBMET03138 0.163 0.063 DBMET03148 0.237 0.029 DBMET03149 0.14 0.085 DBMET03150 0.206 0.04 DBMET03151 0.206 0.04 DBMET03156 | DBMET03149 | |
| 0.126 | 0.075 | 0.126 | Tubulin antagonist | 0.124 0.076 DBMET03146 0.126 0.075 DBMET03150 | ||
| 0.142 | 0.091 | 0.158 | Sigma receptor agonist | 0.119 0.116 DBMET03138 0.158 0.08 DBMET03148 0.127 0.106 DBMET03149 0.142 0.091 DBMET03150 0.119 0.116 DBMET03151 0.119 0.116 DBMET03156 | DBMET03148 | |
| 0.091 | 0.045 | 0.098 | Acetylcholine nicotinic antagonist | 0.098 0.041 DBMET03138 0.089 0.047 DBMET03146 0.087 0.048 DBMET03148 0.077 0.058 DBMET03149 0.091 0.045 DBMET03150 0.098 0.041 DBMET03151 0.098 0.041 DBMET03156 | DBMET03156 | |
| 0.121 | 0.076 | 0.167 | Cyclooxygenase 3 inhibitor | 0.167 0.035 DBMET03146 0.121 0.076 DBMET03150 | DBMET03146 | |
| 0.134 | 0.092 | 0.27 | NOS3 expression enhancer | 0.162 0.062 DBMET03138 0.144 0.079 DBMET03146 0.139 0.085 DBMET03148 0.27 0.023 DBMET03141 0.186 0.047 DBMET03149 0.134 0.092 DBMET03150 0.162 0.062 DBMET03151 0.162 0.062 DBMET03156 0.27 0.023 DBMET03157 | DBMET03157 | |
| 0.058 | 0.017 | 0.06 | Microtubule stabilization | 0.06 0.015 DBMET03138 0.053 0.024 DBMET03139 0.043 0.038 DBMET03140 0.059 0.016 DBMET03146 0.053 0.024 DBMET03141 0.047 0.032 DBMET03142 0.058 0.017 DBMET03150 0.06 0.015 DBMET03151 0.06 0.015 DBMET03156 0.053 0.024 DBMET03157 | DBMET03156 | |
| 0.112 | 0.073 | 0.168 | Cholesterol synthesis inhibitor | 0.114 0.07 DBMET03138 0.099 0.089 DBMET03146 0.142 0.049 DBMET03147 0.168 0.037 DBMET03142 0.112 0.073 DBMET03150 0.114 0.07 DBMET03151 0.142 0.049 DBMET03153 0.114 0.07 DBMET03156 | DBMET03142 | |
| 0.085 | 0.048 | 0.086 | T cell inhibitor | 0.086 0.047 DBMET03138 0.082 0.059 DBMET03146 0.085 0.048 DBMET03150 0.086 0.047 DBMET03151 0.086 0.047 DBMET03156 | DBMET03156 | |
| 0.134 | 0.097 | 0.144 | Ca2+-transporting ATPase inhibitor | 0.144 0.06 DBMET03138 0.144 0.06 DBMET03149 0.134 0.097 DBMET03150 0.144 0.06 DBMET03151 0.144 0.06 DBMET03156 | DBMET03156 | |
| 0.273 | 0.242 | 0.482 | Antiinflammatory | 0.278 0.236 DBMET03138 0.362 0.164 DBMET03140 0.373 0.156 DBMET03147 0.369 0.159 DBMET03148 0.482 0.095 DBMET03141 0.283 0.231 DBMET03142 0.418 0.129 DBMET03149 0.273 0.242 DBMET03150 0.278 0.236 DBMET03151 0.373 0.156 DBMET03153 0.278 0.236 DBMET03156 0.482 0.095 DBMET03157 | DBMET03157 | |
| 0.065 | 0.034 | 0.065 | Dopamine uptake inhibitor | 0.055 0.043 DBMET03138 0.059 0.039 DBMET03148 0.065 0.034 DBMET03150 0.055 0.043 DBMET03151 0.055 0.043 DBMET03156 | ||
| 0.166 | 0.136 | 0.169 | Vasodilator | 0.169 0.133 DBMET03146 0.166 0.136 DBMET03150 | DBMET03146 | |
| 0.077 | 0.049 | 0.101 | Acetylcholine M4 receptor antagonist | 0.101 0.028 DBMET03148 0.07 0.058 DBMET03149 0.077 0.049 DBMET03150 | DBMET03148 | |
| 0.059 | 0.031 | 0.108 | Protein 50S ribosomal subunit inhibitor | 0.058 0.032 DBMET03138 0.049 0.041 DBMET03139 0.108 0.011 DBMET03140 0.057 0.033 DBMET03146 0.1 0.013 DBMET03141 0.059 0.031 DBMET03150 0.058 0.032 DBMET03151 0.058 0.032 DBMET03156 0.1 0.013 DBMET03157 | DBMET03140 | |
| 0.071 | 0.044 | 0.077 | Neuronal nicotinic receptor antagonist | 0.077 0.039 DBMET03138 0.071 0.044 DBMET03146 0.071 0.044 DBMET03148 0.06 0.055 DBMET03149 0.071 0.044 DBMET03150 0.077 0.039 DBMET03151 0.077 0.039 DBMET03156 | DBMET03156 | |
| 0.086 | 0.059 | 0.091 | Acetylcholine agonist | 0.086 0.059 DBMET03138 0.091 0.054 DBMET03148 0.086 0.059 DBMET03150 0.086 0.059 DBMET03151 0.086 0.059 DBMET03156 | DBMET03148 | |
| 0.081 | 0.055 | 0.155 | Glycine receptor antagonist | 0.098 0.035 DBMET03138 0.079 0.059 DBMET03146 0.141 0.01 DBMET03147 0.08 0.056 DBMET03141 0.155 0.006 DBMET03142 0.093 0.04 DBMET03149 0.081 0.055 DBMET03150 0.098 0.035 DBMET03151 0.141 0.01 DBMET03153 0.098 0.035 DBMET03156 0.08 0.056 DBMET03157 | DBMET03142 | |
| 0.16 | 0.134 | 0.283 | Platelet antagonist | 0.151 0.143 DBMET03139 0.283 0.059 DBMET03140 0.245 0.075 DBMET03146 0.151 0.144 DBMET03147 0.281 0.06 DBMET03141 0.167 0.128 DBMET03142 0.16 0.134 DBMET03150 0.151 0.144 DBMET03153 0.281 0.06 DBMET03157 | DBMET03140 | |
| 0.205 | 0.181 | 0.269 | Sodium/bile acid cotransporter inhibitor | 0.218 0.164 DBMET03138 0.206 0.18 DBMET03140 0.201 0.186 DBMET03148 0.2 0.188 DBMET03141 0.219 0.163 DBMET03142 0.269 0.108 DBMET03149 0.205 0.181 DBMET03150 0.218 0.164 DBMET03151 0.218 0.164 DBMET03156 0.2 0.188 DBMET03157 | DBMET03149 | |
| 0.106 | 0.083 | 0.139 | Acetylcholine muscarinic antagonist | 0.131 0.057 DBMET03138 0.113 0.075 DBMET03148 0.139 0.051 DBMET03149 0.106 0.083 DBMET03150 0.131 0.057 DBMET03151 0.131 0.057 DBMET03156 | DBMET03149 | |
| 0.043 | 0.021 | 0.059 | Oxytocin antagonist | 0.043 0.021 DBMET03138 0.04 0.024 DBMET03146 0.059 0.015 DBMET03148 0.05 0.018 DBMET03149 0.043 0.021 DBMET03150 0.043 0.021 DBMET03151 0.043 0.021 DBMET03156 | DBMET03148 | |
| 0.065 | 0.044 | 0.135 | Dopamine D1 antagonist | 0.098 0.026 DBMET03138 0.089 0.029 DBMET03139 0.072 0.038 DBMET03148 0.135 0.017 DBMET03149 0.065 0.044 DBMET03150 0.098 0.026 DBMET03151 0.098 0.026 DBMET03156 | DBMET03149 | |
| 0.144 | 0.123 | 0.144 | DNA methylase inhibitor | 0.144 0.123 DBMET03150 | ||
| 0.04 | 0.021 | 0.069 | Nociceptin (N/OFQ) receptor antagonist | 0.061 0.01 DBMET03138 0.042 0.02 DBMET03146 0.047 0.016 DBMET03148 0.069 0.009 DBMET03149 0.04 0.021 DBMET03150 0.061 0.01 DBMET03151 0.061 0.01 DBMET03156 | DBMET03149 | |
| 0.036 | 0.02 | 0.055 | Vasopressin 2 antagonist | 0.047 0.015 DBMET03138 0.05 0.014 DBMET03148 0.055 0.012 DBMET03149 0.036 0.02 DBMET03150 0.047 0.015 DBMET03151 0.047 0.015 DBMET03156 | DBMET03149 | |
| 0.197 | 0.183 | 0.242 | Apoptosis antagonist | 0.224 0.153 DBMET03138 0.195 0.186 DBMET03146 0.242 0.135 DBMET03149 0.197 0.183 DBMET03150 0.224 0.153 DBMET03151 0.224 0.153 DBMET03156 | DBMET03149 | |
| 0.089 | 0.077 | 0.111 | Alpha 2c adrenoreceptor antagonist | 0.111 0.057 DBMET03148 0.089 0.077 DBMET03150 | DBMET03148 | |
| 0.081 | 0.071 | 0.139 | Alpha adrenoreceptor antagonist | 0.139 0.041 DBMET03148 0.081 0.071 DBMET03150 | DBMET03148 | |
| 0.034 | 0.025 | 0.034 | Tubulin agonist | 0.034 0.024 DBMET03138 0.032 0.03 DBMET03146 0.034 0.025 DBMET03150 0.034 0.024 DBMET03151 0.034 0.024 DBMET03156 | ||
| 0.067 | 0.061 | 0.083 | Glycine receptor agonist | 0.073 0.049 DBMET03138 0.083 0.035 DBMET03146 0.067 0.062 DBMET03149 0.067 0.061 DBMET03150 0.073 0.049 DBMET03151 0.073 0.049 DBMET03156 | DBMET03146 | |
| 0.027 | 0.024 | 0.144 | Estrogen receptor beta agonist | 0.082 0.014 DBMET03138 0.039 0.021 DBMET03147 0.064 0.017 DBMET03148 0.1 0.011 DBMET03142 0.144 0.008 DBMET03149 0.027 0.024 DBMET03150 0.082 0.014 DBMET03151 0.039 0.021 DBMET03153 0.082 0.014 DBMET03156 | DBMET03149 | |
| 0.068 | 0.073 | 0.099 | Estrogen receptor alpha antagonist | 0.073 0.06 DBMET03138 0.077 0.054 DBMET03148 0.099 0.028 DBMET03149 0.073 0.06 DBMET03151 0.073 0.06 DBMET03156 | DBMET03149 | |
| 0.069 | 0.073 | 0.088 | Acetylcholine M3 receptor agonist | 0.088 0.053 DBMET03148 0.071 0.07 DBMET03149 | DBMET03148 | |
| 0.054 | 0.059 | 0.059 | Ryanodine receptor antagonist | 0.059 0.042 DBMET03146 | DBMET03146 | |
| 0.038 | 0.045 | 0.135 | Estrogen agonist | 0.061 0.03 DBMET03138 0.082 0.022 DBMET03147 0.056 0.032 DBMET03148 0.135 0.012 DBMET03142 0.108 0.016 DBMET03149 0.061 0.03 DBMET03151 0.082 0.022 DBMET03153 0.061 0.03 DBMET03156 | DBMET03142 | |
| 0.087 | 0.094 | 0.141 | Cystathionine beta-synthase inhibitor | 0.097 0.08 DBMET03138 0.096 0.082 DBMET03148 0.141 0.045 DBMET03149 0.097 0.08 DBMET03151 0.097 0.08 DBMET03156 | DBMET03149 | |
| 0.02 | 0.029 | 0.03 | Vasopressin 1A antagonist | 0.03 0.019 DBMET03148 0.03 0.019 DBMET03149 | DBMET03149 | |
| 0.06 | 0.07 | 0.096 | Na+ K+ transporting ATPase inhibitor | 0.088 0.043 DBMET03138 0.087 0.044 DBMET03146 0.067 0.063 DBMET03147 0.096 0.035 DBMET03142 0.08 0.05 DBMET03149 0.088 0.043 DBMET03151 0.067 0.063 DBMET03153 0.088 0.043 DBMET03156 | DBMET03142 | |
| 0.018 | 0.028 | 0.032 | Dopamine D1 agonist | 0.026 0.012 DBMET03138 0.021 0.018 DBMET03146 0.022 0.017 DBMET03147 0.032 0.008 DBMET03142 0.028 0.01 DBMET03149 0.026 0.012 DBMET03151 0.022 0.017 DBMET03153 0.026 0.012 DBMET03156 | DBMET03142 | |
| 0.007 | 0.017 | 0.032 | Antibiotic Macrolide-like | 0.032 0.004 DBMET03140 0.03 0.004 DBMET03141 0.03 0.004 DBMET03157 | DBMET03140 | |
| 0.186 | 0.196 | 0.398 | Antithrombotic | 0.213 0.162 DBMET03138 0.194 0.185 DBMET03140 0.216 0.159 DBMET03146 0.398 0.05 DBMET03147 0.209 0.166 DBMET03141 0.346 0.066 DBMET03142 0.213 0.162 DBMET03151 0.398 0.05 DBMET03153 0.213 0.162 DBMET03156 0.209 0.166 DBMET03157 | DBMET03153 | |
| 0.077 | 0.09 | 0.294 | Bronchodilator | 0.294 0.009 DBMET03139 | DBMET03139 | |
| 0.025 | 0.042 | 0.042 | Antidiuretic hormone antagonist | 0.042 0.026 DBMET03148 0.035 0.031 DBMET03149 | DBMET03148 | |
| 0.019 | 0.042 | 0.029 | Vasopressin 1 antagonist | 0.029 0.026 DBMET03148 | DBMET03148 | |
| 0.12 | 0.144 | 0.23 | Antipruritic | 0.151 0.093 DBMET03138 0.194 0.053 DBMET03148 0.23 0.032 DBMET03149 0.151 0.093 DBMET03151 0.151 0.093 DBMET03156 | DBMET03149 | |
| 0.025 | 0.052 | 0.296 | Dopamine D5 antagonist | 0.296 0.004 DBMET03139 0.049 0.026 DBMET03149 | DBMET03139 | |
| 0.084 | 0.112 | 0.121 | Alkylator | 0.097 0.092 DBMET03148 0.121 0.067 DBMET03149 | DBMET03149 | |
| 0.124 | 0.154 | 0.233 | Lipocortins synthesis antagonist | 0.21 0.05 DBMET03148 0.138 0.125 DBMET03141 0.233 0.039 DBMET03149 0.138 0.125 DBMET03157 | DBMET03149 | |
| 0.009 | 0.039 | 0.019 | Nociceptin (N/OFQ) receptor agonist | 0.019 0.017 DBMET03149 | DBMET03149 | |
| 0.048 | 0.08 | 0.057 | Lipocortins synthesis agonist | 0.057 0.041 DBMET03149 | DBMET03149 | |
| 0.01 | 0.049 | 0.04 | Estrogen receptor alpha agonist | 0.04 0.02 DBMET03149 | DBMET03149 | |
| 0.12 | 0.173 | 0.19 | Aldehyde oxidase inhibitor | 0.19 0.11 DBMET03149 | DBMET03149 | |
| 0.062 | 0.124 | 0.137 | Creatine kinase inhibitor | 0.122 0.039 DBMET03138 0.137 0.03 DBMET03149 0.122 0.039 DBMET03151 0.122 0.039 DBMET03156 | DBMET03149 | |
| 0.067 | 0.131 | 0.118 | Anabolic | 0.09 0.078 DBMET03138 0.118 0.042 DBMET03142 0.09 0.078 DBMET03151 0.09 0.078 DBMET03156 | DBMET03142 | |
| 0.101 | 0.177 | 0.173 | Adenylate cyclase stimulant | 0.125 0.114 DBMET03138 0.173 0.032 DBMET03146 0.125 0.114 DBMET03151 0.125 0.114 DBMET03156 | DBMET03146 | |
| 0.024 | 0.108 | 0.081 | Phenylethanolamine N methyltransferase inhibitor | 0.081 0.004 DBMET03146 | DBMET03146 | |
| 0.03 | 0.115 | 0.15 | NMDA 2 receptor antagonist | 0.116 0.025 DBMET03147 0.15 0.016 DBMET03142 0.116 0.025 DBMET03153 | DBMET03142 | |
| 0.128 | 0.217 | 0.156 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.134 DBMET03149 | DBMET03149 | |
| 0.149 | 0.241 | 0.438 | Angiogenesis inhibitor | 0.438 0.043 DBMET03147 0.243 0.128 DBMET03142 0.438 0.043 DBMET03153 | DBMET03153 | |
| 0.138 | 0.231 | 0.194 | DNA synthesis inhibitor | 0.194 0.132 DBMET03138 0.176 0.16 DBMET03141 0.194 0.132 DBMET03151 0.194 0.132 DBMET03156 0.176 0.16 DBMET03157 | DBMET03156 | |
| 0.084 | 0.179 | 0.406 | Angiogenesis stimulant | 0.406 0.021 DBMET03147 0.363 0.029 DBMET03142 0.406 0.021 DBMET03153 | DBMET03153 | |
| 0.141 | 0.239 | 0.294 | Cholesterol antagonist | 0.196 0.168 DBMET03140 0.212 0.154 DBMET03147 0.226 0.143 DBMET03141 0.294 0.095 DBMET03142 0.212 0.154 DBMET03153 0.226 0.143 DBMET03157 | DBMET03142 | |
| 0.136 | 0.239 | 0.223 | RNA-directed DNA polymerase inhibitor | 0.223 0.07 DBMET03147 0.221 0.073 DBMET03142 0.223 0.07 DBMET03153 | DBMET03153 | |
| 0.016 | 0.124 | 0.049 | Dopamine D5 agonist | 0.049 0.018 DBMET03146 | DBMET03146 | |
| 0.055 | 0.169 | 0.109 | 5 Hydroxytryptamine 2B antagonist | 0.109 0.073 DBMET03148 | DBMET03148 | |
| 0.122 | 0.243 | 0.183 | Superoxide dismutase inhibitor | 0.17 0.155 DBMET03146 0.183 0.138 DBMET03147 0.175 0.148 DBMET03142 0.183 0.138 DBMET03153 | DBMET03153 | |
| 0.146 | 0.269 | 0.221 | Tyrosine 3 hydroxylase inhibitor | 0.221 0.102 DBMET03149 | DBMET03149 | |
| 0.03 | 0.154 | 0.068 | Histidine decarboxylase inhibitor | 0.068 0.053 DBMET03149 | DBMET03149 | |
| 0.081 | 0.206 | 0.131 | Arachidonic acid antagonist | 0.131 0.112 DBMET03149 | DBMET03149 | |
| 0.056 | 0.182 | 0.111 | Protein kinase C zeta inhibitor | 0.111 0.039 DBMET03147 0.111 0.039 DBMET03153 | DBMET03153 | |
| 0.004 | 0.144 | 0.022 | Estrone sulfatase inhibitor | 0.022 0.015 DBMET03142 | DBMET03142 | |
| 0.011 | 0.158 | 0.039 | Estradiol 17 beta-dehydrogenase inhibitor | 0.039 0.032 DBMET03149 | DBMET03149 | |
| 0.148 | 0.302 | 0.412 | Antibacterial | 0.222 0.205 DBMET03138 0.395 0.079 DBMET03140 0.412 0.071 DBMET03141 0.327 0.116 DBMET03142 0.222 0.205 DBMET03151 0.222 0.205 DBMET03156 0.412 0.071 DBMET03157 | DBMET03157 | |
| 0.081 | 0.238 | 0.189 | Insulin secretagoues | 0.189 0.042 DBMET03141 0.189 0.042 DBMET03157 | DBMET03157 | |
| 0.051 | 0.222 | 0.183 | Multidrug resistance-associated protein 1 inhibitor | 0.174 0.017 DBMET03147 0.111 0.06 DBMET03148 0.183 0.014 DBMET03142 0.095 0.088 DBMET03149 0.174 0.017 DBMET03153 | DBMET03142 | |
| 0.098 | 0.287 | 0.259 | Hypoglycemic | 0.168 0.15 DBMET03140 0.259 0.071 DBMET03141 0.186 0.127 DBMET03149 0.259 0.071 DBMET03157 | DBMET03157 | |
| 0.048 | 0.246 | 0.112 | Toll-Like receptor 9 antagonist | 0.112 0.096 DBMET03148 | DBMET03148 | |
| 0.072 | 0.282 | 0.173 | Immunostimulant | 0.173 0.137 DBMET03147 0.164 0.143 DBMET03142 0.173 0.137 DBMET03153 | DBMET03153 | |
| 0.023 | 0.239 | 0.09 | Androgen antagonist | 0.09 0.055 DBMET03149 | DBMET03149 | |
| 0.13 | 0.358 | 0.223 | Interleukin 2 agonist | 0.223 0.152 DBMET03141 0.223 0.152 DBMET03157 | DBMET03157 | |
| 0.042 | 0.271 | 0.135 | Lipid peroxidase inhibitor | 0.135 0.079 DBMET03149 | DBMET03149 | |
| 0.025 | 0.266 | 0.106 | MAO inhibitor | 0.103 0.088 DBMET03139 0.106 0.085 DBMET03149 | DBMET03149 | |
| 0.052 | 0.297 | 0.078 | CC chemokine 5 receptor agonist | 0.078 0.072 DBMET03149 | DBMET03149 | |
| 0.014 | 0.262 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 DBMET03147 0.025 0.024 DBMET03142 0.031 0.01 DBMET03153 | DBMET03153 | |
| 0.118 | 0.378 | 0.21 | Calcium channel activator | 0.21 0.198 DBMET03146 | DBMET03146 | |
| 0.011 | 0.275 | 0.09 | HIV-1 integrase (Strand Transfer) inhibitor | 0.073 0.034 DBMET03147 0.09 0.027 DBMET03142 0.073 0.034 DBMET03153 | DBMET03142 | |
| 0.024 | 0.327 | 0.065 | Ca(v)3.2 blocker | 0.059 0.041 DBMET03148 0.065 0.029 DBMET03149 | DBMET03149 | |
| 0.005 | 0.354 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 DBMET03142 | DBMET03142 | |
| 0.009 | 0.372 | 0.075 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.048 DBMET03147 0.075 0.036 DBMET03142 0.059 0.048 DBMET03153 | DBMET03142 | |
| 0.048 | 0.418 | 0.195 | Hemostatic | 0.158 0.059 DBMET03147 0.195 0.034 DBMET03142 0.158 0.059 DBMET03153 | DBMET03142 | |
| 0.025 | 0.403 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.026 DBMET03147 0.058 0.033 DBMET03142 0.061 0.026 DBMET03153 | DBMET03153 | |
| 0.008 | 0.423 | 0.147 | Selectin antagonist | 0.075 0.04 DBMET03140 0.147 0.018 DBMET03147 0.087 0.033 DBMET03141 0.092 0.031 DBMET03142 0.147 0.018 DBMET03153 0.087 0.033 DBMET03157 | DBMET03153 | |
| 0.08 | 0.496 | 0.231 | GABA C receptor rho-3 antagonist | 0.231 0.172 DBMET03149 | DBMET03149 | |
| 0.038 | 0.463 | 0.077 | Ca(v)3.1 blocker | 0.077 0.071 DBMET03148 0.076 0.075 DBMET03149 | DBMET03148 | |
| 0.016 | 0.5 | 0.148 | Protein-tyrosine phosphatase inhibitor | 0.124 0.108 DBMET03147 0.148 0.08 DBMET03142 0.124 0.108 DBMET03153 | DBMET03142 | |
| 0.014 | 0.507 | 0.156 | Diuretic | 0.156 0.072 DBMET03142 | DBMET03142 | |
| 0.012 | 0.56 | 0.035 | Glutamate (mGluR8) antagonist | 0.035 0.026 DBMET03141 0.035 0.026 DBMET03157 | DBMET03157 | |
| 0.004 | 0.579 | 0.046 | 5 Hydroxytryptamine 2C agonist | 0.046 0.031 DBMET03146 | DBMET03146 | |
| 0.015 | 0.61 | 0.158 | Thrombolytic | 0.123 0.107 DBMET03140 0.158 0.076 DBMET03141 0.158 0.076 DBMET03157 | DBMET03157 | |
| 0.015 | 0.615 | 0.166 | Dual specificity phosphatase 3 inhibitor | 0.163 0.085 DBMET03147 0.166 0.083 DBMET03142 0.163 0.085 DBMET03153 | DBMET03142 | |
| 0.003 | 0.645 | 0.094 | Cholecystokinin antagonist | 0.094 0.009 DBMET03142 | DBMET03142 | |
| 0.003 | 0.679 | 0.067 | Cholecystokinin B antagonist | 0.027 0.024 DBMET03147 0.067 0.007 DBMET03142 0.027 0.024 DBMET03153 | DBMET03142 | |
| 0.013 | 0.701 | 0.148 | Dual specificity phosphatase inhibitor | 0.144 0.101 DBMET03147 0.148 0.096 DBMET03142 0.144 0.101 DBMET03153 | DBMET03142 | |
| 0.008 | 0.726 | 0.45 | Cholecystokinin B agonist | 0.23 0.004 DBMET03147 0.45 0.003 DBMET03142 0.23 0.004 DBMET03153 | DBMET03142 | |
| 0.027 | 0.747 | 0.249 | Cyclophilin D inhibitor | 0.249 0.215 DBMET03141 0.249 0.215 DBMET03157 | DBMET03157 | |
| 0.012 | 0.769 | 0.08 | Factor IXa inhibitor | 0.08 0.016 DBMET03147 0.08 0.016 DBMET03153 | DBMET03153 | |
| 0.007 | 0.768 | 0.274 | Anticoagulant | 0.274 0.033 DBMET03147 0.226 0.045 DBMET03142 0.274 0.033 DBMET03153 | DBMET03153 | |
| 0.017 | 0.792 | 0.142 | MAP3K9 inhibitor | 0.142 0.073 DBMET03146 | DBMET03146 | |
| 0.003 | 0.795 | 0.109 | Cholecystokinin A antagonist | 0.042 0.023 DBMET03147 0.109 0.007 DBMET03142 0.042 0.023 DBMET03153 | DBMET03142 | |
| 0.005 | 0.801 | 0.067 | Elastase inhibitor | 0.067 0.024 DBMET03139 | DBMET03139 | |
| 0.002 | 0.805 | 0.221 | Cholecystokinin agonist | 0.124 0.004 DBMET03147 0.221 0.003 DBMET03142 0.124 0.004 DBMET03153 | DBMET03142 | |
| 0.004 | 0.815 | 0.04 | NMDA 2D receptor antagonist | 0.04 0.01 DBMET03147 0.04 0.01 DBMET03153 | DBMET03153 | |
| 0.002 | 0.854 | 0.174 | Cholecystokinin A agonist | 0.105 0.004 DBMET03147 0.174 0.003 DBMET03142 0.105 0.004 DBMET03153 | DBMET03142 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |